1. Introduction {#s0005}
===============

Impairments in skeletal muscle mitochondrial function and content have been implicated in the development of sarcopenia, the age-related loss of muscle mass and performance ([@bb0015]; [@bb0170]; [@bb0100]). The assessment of skeletal muscle mitochondria presents challenges. Assessment of content, such as staining for cytochrome oxidase, requires the collection of muscle tissue, as do *in vitro* measures of function such as respirometry of isolated mitochondria ([@bb0090]). *In vivo* measurement of function is possible using phosphorous magnetic resonance spectroscopy (^31^P-MRS), requiring participants to undertake controlled exercise sufficient to deplete muscle reserves of phosphocreatine ([@bb0095]).

As expected for an age-related condition, sarcopenia is most common among the very old ([@bb0060]), with a prevalence of 21% in a sample of 85-year-olds ([@bb0080]). There have been few studies of mitochondrial function and content in this age group, with relevant studies typically having a mean age below 85 ([@bb0035]; [@bb0030]; [@bb0160]; [@bb0140]; [@bb0070]). The opportunity to collect muscle samples during hip fracture surgery has been used to investigate whether impaired mitochondrial homeostasis is associated with sarcopenia among the very old ([@bb0120]). Older patients with hip fracture are recognised to have not only high levels of sarcopenia but also disability and multimorbidity ([@bb0065]; [@bb0105]); in this setting, the influences of ageing *per se* and those of acute illness and overall frailty may be difficult to disentangle.

A complementary approach is to study community-dwelling very old individuals, including those with few medical and functional problems, who may provide important insights into factors that promote healthy ageing ([@bb0085]). We therefore undertook a pilot study in which we assessed the feasibility of recruiting community-dwelling 85-year-old people to attend for detailed phenotyping including ^31^P-MRS and muscle biopsy. The aim of the present study was to determine if skeletal muscle mitochondrial respiratory chain function and content are preserved among healthy 85-year-olds.

2. Methods {#s0010}
==========

2.1. Participants {#s0015}
-----------------

We recruited participants aged 85 years, born in 1931, who were registered with a general practice within the North East & North Cumbria Clinical Research Network, England. We excluded those with a cardiac pacemaker or any other metallic or programmable device (*e*.*g*. cochlear implants or surgical clips) or those who were taking anticoagulant drugs. We also excluded individuals considered unsuitable for approach by their general practitioner (GP). All participants needed to have capacity to provide written informed consent.

Potential participants were identified through their GPs and were sent a letter of invitation, a study information pack and a letter of support from their GP. Individuals expressing an interest in the study were then contacted by the research team and an appointment made to visit them in their own home. At this visit, the requirements of the study were discussed in detail and initial informed consent obtained. Endurance of consent was verified at each contact and prior to any research procedure throughout the research process. The study was approved in the UK by the Tyne & Wear South Research Ethics Committee (15/NE/0382). Fieldwork took place between May and August 2016.

We asked participants whether they had ever been diagnosed by a doctor with 11 common conditions (heart attack, congestive heart failure, angina, stroke/mini-stroke/TIA, hypertension, diabetes, asthma, depression, chronic lung disease, kidney disease or cancer) and recorded their regular prescribed medications. We used the 15-item geriatric depression scale (GDS) and the mini-mental state examination (MMSE) to assess mood and cognition, respectively. We enquired about difficulty or needing help across 17 activities of daily living such as dressing/undressing, cutting toenails, shopping and managing finances. We used the Short Form 36 (SF-36) Health Survey Questionnaire to derive general health and physical functioning scores ([@bb0185]). We assessed physical activity using the rapid assessment of physical activity (RAPA), deriving scores for aerobic activity (1--7, with 7 being most active) and strength and flexibility activity (0--3, with 3 most being active) ([@bb0180]).

2.2. Identification of sarcopenia {#s0020}
---------------------------------

We measured grip strength (kg) with a Jamar handheld hydraulic dynamometer (Promedics, UK) using three trials in both hands following a standard protocol ([@bb0130]) and using the maximum value obtained for analyses. Participants completed the Timed Up-and-Go (TUG) test: a stopwatch was used to measure the time taken to get up from a chair and walk as quickly and safely as possible up to and around a marker placed 3 m away, walk back to the chair and sit back down. We converted this time to an estimate of gait speed (m/s) using the formula (6 / \[TUG time\]) ∗ 1.62 ([@bb0045]; [@bb0050]). We measured total body weight (kg) and estimated appendicular lean mass (kg) using a Tanita MC-780MA body composition analyser (Tanita Corporation, Arlington Heights, IL.). We estimated height based on demi-span, measured twice to the nearest millimetre. We calculated skeletal muscle index (SMI) (kg/m^2^) from appendicular lean mass divided by height-squared. We applied the European Working Group sarcopenia definition to our results, using recognised cut-points for grip strength of \<30 kg in men and \<20 kg in women, for gait speed of ≤0.8 m/s and for SMI of \<7.26 kg/m^2^ in men and \<5.45 kg/m^2^ in women ([@bb0055]). We considered participants with weak grip and/or slow gait speed, in combination with low SMI, to have sarcopenia.

2.3. Phosphorous magnetic resonance spectroscopy {#s0025}
------------------------------------------------

Participants attended for ^31^P-MRS scanning and were requested to perform a low-intensity plantar flexion exercise in the scanner with incremental loading, until the phosphocreatine in the gastrocnemius and soleus muscles was depleted by approximately 50%. Measurements were taken every 10 s during exercise and recovery. We fitted an exponential recovery curve to the area under the phosphocreatine peak from which we modelled the time taken, τ~1/2~ PCr (seconds), for recovery halfway to baseline, as a measure of mitochondrial oxidative function, with shorter times implying higher function ([@bb0095]) ([Fig. 1](#f0005){ref-type="fig"}).Fig. 1Assessment of mitochondrial function and content.Sample results for mitochondrial function and content (NB two different participants are shown). A. Exponential recovery curve for phosphocreatine following exercise. τ~1/2~ PCr for participant shown is 36.6 s. B. Quadruple immunofluorescence. Mean Z-scores from participant shown of 0.6 for complex IV (MTCOI) and 0.1 for complex I (NDUFB8).Fig. 1

2.4. Muscle biopsy {#s0030}
------------------

We obtained biopsy of the vastus lateralis muscle under local anaesthesia from seven participants using a Weil Blakesley conchotome. The samples were snap frozen in isopentane cooled in liquid nitrogen. We telephone participants the following day to check their wellbeing and visited them at home one week after their biopsy to check the wound had healed and that there were no signs of infection present. We also enquired about any pain at the site, rated on a scale of 0 (no pain) -- 10 (worst pain).

2.5. Quadruple immunofluorescence {#s0035}
---------------------------------

Two 10 μm sections from each biopsy were used for the quadruple immunofluorescence with antibodies to laminin, NDUFB8 (subunit of complex I), MTCOI (subunit of complex IV) and porin, as described previously ([@bb0140]; [@bb0135]) ([Fig. 1](#f0005){ref-type="fig"}). Control samples were biopsies obtained from five younger patients undergoing orthopaedic surgery (see [Supplementary Table 1](#ec0005){ref-type="supplementary-material"} for full details). The control and participant sections were reacted the same day with the same batch of antibody and identical concentrations. All exposure times were set and maintained throughout the imaging.

The immunofluorescence data from the fibres in the control samples were used to produce linear regression models for the relationships between levels of complex I and porin, and between complex IV and porin. The regression findings were then used to predict the expected levels of complex I and IV per fibre among study participants based on the fibres\' measured porin levels. The measured values in complex I and IV were then expressed as *Z*-scores (the number of standard deviations the measured values were above that predicted by the linear regression models). We classified fibres with Z ≥ −3 (so measured values no lower than 3 standard deviations below that predicted from the relationships seen in young controls) as positive.

2.6. Statistical analyses {#s0040}
-------------------------

We calculated descriptive statistics for the variables of interest and tested for differences between participants who did and did not undergo muscle biopsy using the Wilcoxon Rank-Sum test. We performed all analyses using Stata version 14.0 ([@bb0165]).

3. Results {#s0045}
==========

[Table 1](#t0005){ref-type="table"} shows the characteristics of the 19 participants recruited to the study. They had a median of two diseases and high levels of self-reported physical function and general health, especially among the women in the sample and when compared to normative data for the same age group ([@bb0010]). They regularly engaged in aerobic physical activity with a mean RAPA score of 4.8 (1.4). Their mean results for the components of sarcopenia were either above the relevant cut-points (gait speed, SMI) or just below (grip strength); as such only one participant had sarcopenia according to the EWGSOP definition.Table 1Sample characteristics.Table 1Characteristic\
Mean (SD) unless shown otherwiseMen (*n* = 8)Women (*n* = 11)All (*n* = 19)Age at interview (years)84.9 (0.3)85.0 (0.3)85.0 (0.3)Disease count \[median (IQR)\]3 (2,3)1 (1,3)2 (1, 3)No. of prescribed medications \[median (IQR)\]7 (3,14)5 (4,6)6 (3, 11)Geriatric depression score2 (1,2)1 (0,2)1 (0, 2)Mini-mental state examination score29 (29,30)30 (29,30)29 (29, 30)Number of ADLs with difficulty/help needed2 (0,3)0 (0,2)1 (0, 2)SF-36 self-reported physical function (0−100)[a](#tf0005){ref-type="table-fn"}64.2 (23.4)79.4 (16.5)73.1 (20.6)SF-36 self-reported general health (0--100)[a](#tf0005){ref-type="table-fn"}70 (9.6)79.6 (10.1)75.5 (10.8)RAPA aerobic activity score (1--7)[a](#tf0005){ref-type="table-fn"}4.6 (1.6)5 (1.3)4.8 (1.4)RAPA strength and flexibility score (0--3)[a](#tf0005){ref-type="table-fn"}0.9 (1.0)0.6 (0.8)0.7 (0.9)Grip strength (kg)29.9 (6.2)19.1 (6.1)N/AGait speed (m/s)0.9 (0.4)1.1 (0.3)1.0 (0.3)BMI (kg/m^2^)27.6 (3.1)24.4 (4.2)25.7 (4.0)SMI (kg/m^2^)8.1 (0.8)6.4 (1.0)N/AEWGSOP sarcopenia \[n (%)\]1 (12.5%)0 (0%)1 (5.3%)[^1][^2]

3.1. Mitochondrial function assessed using magnetic resonance spectroscopy {#s0050}
--------------------------------------------------------------------------

We collected valid ^31^P-MRS data in 16 participants (one was unable to attend, one declined the scan and in one participant their phosphocreatine did not deplete adequately during exercise). The mean τ~1/2~ PCr was 35.6 (11.3) seconds, in keeping with preserved mitochondrial oxidative capacity ([@bb0095]). The scan procedure was well tolerated by all participants who undertook the test.

3.2. Mitochondrial content assessed using quadruple immunofluorescence {#s0055}
----------------------------------------------------------------------

Seven participants had a muscle biopsy collected. Reasons for non-participation included the presence of visible veins over the planned biopsy site (*n* = 5), use of medications that could increase risk of bleeding or poor wound-healing (*n* = 3) and participants being unavailable (*n* = 1) or unwilling (n = 3) to have biopsy. We saw no differences in the baseline characteristics (as shown in [Table 1](#t0005){ref-type="table"}) between those participants who did and those who did not have muscle biopsy. There was little evidence of deficiency in men or women of either of the two mitochondrial respiratory chain complexes tested, as shown in [Table 2](#t0010){ref-type="table"}. There were no complications noted at the follow-up home visit and none of the seven participants reported any pain at the biopsy site.Table 2Mitochondrial function and content.Table 2Characteristic\
Mean (SD)MenWomenAllPhosphorous magnetic resonance spectroscopy*n* = 6*n* = 10*n* = 16 Phosphocreatine recovery rate, τ~1/2~ PCr (s)33.1 (8.6)37.0 (12.9)35.6 (11.3)Quadruple immunofluorescencen = 3*n* = 4*n* = 7 Complex I Mean fibre *Z*-score−0.5 (1.1)−0.7 (0.4)−0.7 (0.7) Proportion of positive fibres (Z ≥ −3) (%)98.9 (1.4)98.6 (0.2)98.7 (0.9) Complex IV Mean fibre Z-score0.0(0.4)−0.3 (0.5)−0.2 (0.4) Proportion of positive fibres (Z ≥ −3) (%)99.4 (0.4)98.8 (0.3)99.1 (0.5)

4. Discussion {#s0060}
=============

In this pilot study we carried out an initial investigation of skeletal muscle mitochondrial respiratory chain function and content in an active and healthy sample of 85-year-olds, among whom sarcopenia was uncommon. We found that phosphocreatine recovery time from ^31^P-MRS (in 17 participants) and levels of subunits of complexes I and IV from quadruple immunofluorescence (in 7 participants) were preserved. Both assessments were well tolerated.

Reduction in content and changes to the functions of skeletal muscle mitochondria including reduced respiratory chain function, sensitisation to permeability transition and impaired quality control may contribute to the development of sarcopenia ([@bb0090]; [@bb0115]). In addition to those used in the present study, a range of techniques have been used to investigate these changes. For content these include histochemistry of enzymes such as cytochrome *c* oxidase ([@bb0015]) and mtDNA copy number ([@bb0155]). For functions they include *ex*-*vivo* measurement of respiration in permeabilized myofibres ([@bb0160]; [@bb0070]) and Western immunoblotting of proteins regulating quality control processes ([@bb0120]).

There is debate on the extent to which age-related changes in mitochondria represent a primary organelle defect or occur secondary to concomitant reductions in physical activity and cardiorespiratory fitness. Several studies have compared the mitochondrial function and content in young active individuals to that seen in older active and older sedentary groups ([@bb0170]; [@bb0160]; [@bb0145]; [@bb0075]) and to that seen in sedentary individuals across a range of ages ([@bb0070]). They have shown that increased habitual physical activity appears to attenuate age-related declines in mitochondrial function and content, with evidence from exercise intervention studies supporting this ([@bb0025]; [@bb0110]). Therefore, the regular aerobic activity undertaken by participants in our study may have contributed to the preserved mitochondrial function and content.

We are not aware of other data for ^31^P-MRS of the gastrocnemius and soleus muscles in the very old. Taylor et al. previously reported a similar mean τ~1/2~ PCr of 32 s in these muscles following exercise in a sample of six healthy men and women aged 70--83 years ([@bb0175]). Two previous studies have reported ^31^P-MRS data for the quadriceps from three samples with mean ages between 72 and 79 years ([@bb0150]; [@bb0195]), expressed as the recovery rate constant, k~PCr~. If we assume that the two muscle sites are comparable and convert k~PCr~ to τ~1/2~ PCr (using the formula τ~1/2~ PCr = −ln(0.5) / k~PCr~), then their summary values are again similar to our own: ranging from 33.0 to 36.5 s. It is likely that we do not see abnormally long values in our older sample as they regularly engage in aerobic physical activity. This has been shown to have marked benefits for function assessed by ^31^P-MRS of the quadriceps in a sample of young men ([@bb0190]), and more recently when comparing older active and sedentary individuals at mean ages 68 and 71, respectively ([@bb0075]).

We also saw largely positive fibres on quadruple immunofluorescence, with mean *Z*-scores of the complex I and IV subunits in the positive range (Z ≥ −3), as we previously reported in a sample of community-dwelling older men at mean age 73 ([@bb0140]). The high level of physical activity undertaken by our participants may have attenuated the age-related decline in mitochondrial respiratory enzyme content ([@bb0170]; [@bb0075]; [@bb0020]).

We found that it was feasible to undertake ^31^P-MRS including exercise of the calf muscles in a healthy sample of 85-year-olds and that the procedure was well tolerated. The majority of participants were also willing to undergo biopsy and those who did reported little discomfort following the procedure, in keeping with existing research ([@bb0125]; [@bb0005]). We exercised caution when deciding to proceed with biopsy, for example excluding participants with visible veins around the biopsy site. Understanding more about the acceptability and feasibility of muscle biopsy in the very old would allow cellular and molecular mechanistic studies in this age group to flourish.

This study had several strengths. We successfully recruited a sample of healthy 85-year-old people for detailed phenotyping related to skeletal muscle. We carried out an initial home visit, giving participants opportunity to meet a member of the study team and discuss what the study involved; this has previously been linked to engagement with intensive assessments such as muscle biopsy ([@bb0005]).

Limitations of this study include the fact that we assessed physical activity using a questionnaire; an objective measurement would have given us useful additional information regarding the intensity and patterns of activity. We did not attempt muscle biopsy in around two-thirds of participants, mainly due to skin changes or medication history. Our sample was also biased towards healthier and more active participants, among whom sarcopenia and other conditions were less common than average for this age group ([@bb0080]; [@bb0040]). This may in part reflect the study\'s exclusion criteria: for example, those taking anticoagulant drugs are more likely to have cardiovascular disease than the general population. The small sample size of our study prevented us from examining associations between mitochondrial function/content and the components of sarcopenia. The small sample sizes and variability of the measures we report also suggest that the mean values we show in [Table 2](#t0010){ref-type="table"} may well not be representative of the underlying population.

In conclusion, we found that skeletal muscle respiratory chain function, assessed using ^31^P-MRS, and the content of two respiratory chain subunits in muscle biopsy samples were preserved in a healthy, active sample of 85-year-old men and women. This is likely to reflect the fact that our sample reported regularly engaging in aerobic exercise. These results will help to inform future studies in this age group, including in those with lower activity levels and higher levels of sarcopenia than in this pilot study.

Declarations

Funding {#s0065}
=======

This study was funded by a Medical Research Council Confidence in Concept grant to AAS.

The research was supported by the NIHR Newcastle Biomedical Research Centre awarded to the Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Wellcome Centre for Mitochondrial Research (203105/Z/16/Z), the Medical Research Council (MRC) Centre for Translational Research in Neuromuscular Disease, Newcastle University Centre for Ageing and Vitality (supported by the Biotechnology and Biological Sciences Research Council and MRC) and Mitochondrial Disease Patient Cohort (UK) (G0800674). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

The following is the supplementary data related to this article.Supplementary Table 1Details of controls.Five younger patients gave written consent for muscle biopsy at the time of orthopaedic surgery.Supplementary Table 1

Conflicts of interest {#s0070}
=====================

The authors have no conflicts of interest to declare.

We would like to thank the participants in this study, the team at the Clinical Ageing Research Unit at Newcastle upon Tyne Hospitals NHS Foundation Trust and Gavin Falkous (Wellcome Trust Centre for Mitochondrial Research) for processing the muscle biopsy samples.
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